Oncogenic KrasG12D causes myeloproliferation via NLRP3 inflammasome activation
Open Access
- 3 April 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Communications
- Vol. 11 (1), 1-17
- https://doi.org/10.1038/s41467-020-15497-1
Abstract
Oncogenic Ras mutations occur in various leukemias. It was unclear if, besides the direct transforming effect via constant RAS/MEK/ERK signaling, an inflammation-related effect of KRAS contributes to the disease. Here, we identify a functional link between oncogenic KrasG12D and NLRP3 inflammasome activation in murine and human cells. Mice expressing active KrasG12D in the hematopoietic system developed myeloproliferation and cytopenia, which is reversed in KrasG12D mice lacking NLRP3 in the hematopoietic system. Therapeutic IL-1-receptor blockade or NLRP3-inhibition reduces myeloproliferation and improves hematopoiesis. Mechanistically, KrasG12D-RAC1 activation induces reactive oxygen species (ROS) production causing NLRP3 inflammasome-activation. In agreement with our observations in mice, patient-derived myeloid leukemia cells exhibit KRAS/RAC1/ROS/NLRP3/IL-1β axis activity. Our findings indicate that oncogenic KRAS not only act via its canonical oncogenic driver function, but also enhances the activation of the pro-inflammatory RAC1/ROS/NLRP3/IL-1β axis. This paves the way for a therapeutic approach based on immune modulation via NLRP3 blockade in KRAS-mutant myeloid malignancies.Keywords
This publication has 43 references indexed in Scilit:
- MEK inhibitors selectively suppress alloreactivity and graft-versus-host disease in a memory stage-dependent mannerBlood, 2013
- The prognostic impact of K-RAS mutations in adult acute myeloid leukemia patients treated with high-dose cytarabineOncoTargets and Therapy, 2011
- The InflammasomesCell, 2010
- STAT-3 and ERK 1/2 phosphorylation are critical for T-cell alloactivation and graft-versus-host diseaseBlood, 2008
- Juvenile myelomonocytic leukemia: A report from the 2nd International JMML SymposiumLeukemia Research, 2008
- ATP Activates a Reactive Oxygen Species-dependent Oxidative Stress Response and Secretion of Proinflammatory Cytokines in MacrophagesJournal of Biological Chemistry, 2007
- Restoration of p53 function leads to tumour regression in vivoNature, 2007
- Non‐hematopoietic stem cell transplantation treatment of juvenile myelomonocytic leukemia: A retrospective analysis and definition of response criteriaPediatric Blood & Cancer, 2006
- The NF1 Gene in Myelopoiesis and Childhood Myelodysplastic SyndromesNew England Journal of Medicine, 1994
- Interleukin 1-dependent paracrine granulopoiesis in chronic granulocytic leukemia of the juvenile type.JCI Insight, 1988